Ana L. I.
- Country
- Spain
- Department
- Department of Urology
Research Overview
Data & Insights
Has run more than one trial at 22 of 37 partner sites.
Specializations
Urologic Oncology
The investigator specializes in the treatment of non-muscle invasive bladder cancer (NMIBC), with particular focus on developing innovative therapeutic approaches for patients with intermediate risk conditions.
- Bladder Cancer Management
- Risk-stratified Treatment Approaches
- Novel Therapeutic Interventions
Their research encompasses the evaluation of advanced therapeutic options for bladder cancer patients following transurethral resection procedures.
Disease Recurrence Prevention
The investigator focuses on developing strategies to prevent cancer recurrence and progression in bladder cancer patients, particularly evaluating new therapeutic agents against standard observation protocols.
- Cancer Surveillance Protocols
- Risk Assessment Methods
- Treatment Timing Optimization
Their work includes evaluation of periodic treatment interventions and their impact on disease outcomes.
Therapeutic Innovation
The investigator studies novel gene therapy approaches in urologic oncology, with emphasis on investigating new treatment modalities for bladder cancer management.
- Intravesical Therapies
- Treatment Response Assessment
- Long-term Outcome Evaluation
Their research includes assessment of treatment tolerability and therapeutic efficacy in bladder cancer interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.